DeuterOncology
Geel · Founded 2020
About DeuterOncology
DeuterOncology is a preclinical-stage biotech company focusing on the development of a first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2023)
- Website: https://www.deuteroncology.com
Industries & Categories
Biotechnology, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/deuteroncology-25406 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.